During the past decade, Revmatologicky ustav - Lekarna conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Revmatologicky ustav - Lekarna" are "Arthritis, Psoriatic" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Revmatologicky ustav - Lekarna" in a lesser frequency.

Most popular intervention types in "Revmatologicky ustav - Lekarna" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab" (1 trials), "Methotrexate" (1 trials), "Placebo" (1 trials), "Placebo Methotrexate" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Revmatologicky ustav - Lekarna" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Revmatologicky ustav - Lekarna". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Revmatologicky ustav - Lekarna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Revmatologicky ustav - Lekarna, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".